NCT03967899View on ClinicalTrials.gov

Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

October 31, 2020

Study Completion Date

October 28, 2021

Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03967899 - Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Biotech Hunter | Biotech Hunter